MCMichael J. Crowther

Michael J. Crowther

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael J. Crowther has a total of 167 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Framework for the Estimation of Quality-Adjusted Life-Years Using Joint Models of Longitudinal and Survival Data

    by Michael J. Crowther, Alessandro Gasparini, Sara Ekberg, Federico Felizzi, Elaine Gallagher, Noman Paracha

    Background: Length and quality of life are frequently combined in health technology assessments to derive a single, generic measure of health improvement due to a treatment or medicine. One such measure is given by quality-adjusted life-years (QALYs), typically calculated assuming discrete health states and quality-of-life values. The accurate estimation of QALYs is crucial for informed decision making in health care policy and resource allocation; however, traditional methods often rely on assumptions that are sometimes biologically and statistically inappropriate. This study aims to develop a framework for estimating QALYs in populations where survival data are collected that addresses these limitations. Methods: A framework for estimating QALYs in continuous time is introduced, based on joint longitudinal-survival models fitted using maximum likelihood; the proposed framework requires patient-level data, including longitudinal health utility values and overall survival. In contrast to the conventional approach, which involves dichotomising health states and separate models, this method allows the estimation of QALYs from a single model while accounting for all the statistical and biological intricacies of the data, providing a more appropriate estimate for cost-effectiveness modeling. The joint modeling approach is validated using Monte Carlo simulation under realistic data-generating mechanisms. Results: Simulations showed that the joint longitudinal-survival modeling approach could recover the true QALYs without bias. Conversely, a comparison method based on calculating QALYs directly from the health utility trajectories, ignoring the survival process, was biased under most scenarios. Conclusions: A new methodology for estimating QALYs within a unified, flexible and extensible framework has been developed. This approach can improve QALY estimation and their use in cost-effectiveness analyses in practice, enabling more timely and robust health technology assessments. User-friendly Stata software is provided.

  • Open Access

    Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular Dystrophy

    by Jonathan Broomfield, Keith R. Abrams, Michael J. Crowther, Michela Guglieri, Nicholas R Latimer, Mark J. Rutherford

    Introduction. Cost-effectiveness analyses are vital in guiding decisions on treatment reimbursement. Natural history models are central to these, enabling the estimation of long-term costs and quality-adjusted life-years (QALYs) in the absence of lifetime trial data. Rare disease data are often scarce, resulting in disease progression being estimated through clinical assumptions. This study aims to evaluate how different modeling approaches influence cost-effectiveness estimates in rare disease health technology assessments (HTAs), using Duchenne muscular dystrophy (DMD) as a case study. Methods. A published economic model was used to compare 2 approaches for estimating disease progression: an assumption-based method relying on clinical plausibility and data-driven methods using data from 1,005 patients with DMD across 8 studies. Transition probabilities were estimated assuming increasing flexibility of study heterogeneity and compared with a simulated treatment cohort. Models were evaluated by comparing incremental cost-effectiveness ratios (ICERs) across approaches. No gold standard exists, so the plausibility of predictions was evaluated by comparing survival and disease progression estimates to published milestones. Results. Results showed that although the assumption-based model was clinically plausible, it predicted higher QALY gains (0.77) and lower ICERs (£1.96M per QALY) than data-driven methods did, which estimated QALY gains of 0.25, 0.26, 0.27, and 0.28 and ICERs of £6.2M, £6.2M, £5.8M, and £5.7M per QALY for the least to most flexible models, respectively. Limitations. No covariate effects or updated cost and utility data were incorporated, as the study purpose was a methodological comparison between approaches. Analyses were deterministic not probabilistic. Conclusions and Implications. This study emphasizes the critical role of model selection for HTA in rare diseases, showing that cost-effectiveness estimates from robust data-driven approaches can differ from clinically plausible assumption-based models. Highlights: The choice of a natural history modeling method can drastically alter the cost-effectiveness results in rare disease evaluations. A case study in Duchenne muscular dystrophy demonstrates how different modeling approaches yield divergent cost-effectiveness outcomes. Assumption-based models, even when clinically plausible, may underestimate measures of cost-effectiveness and result in less reliable guidance for decision makers. Data-driven models using real-world patient data provide more reliable estimates for health technology assessment (HTA). This study offers practical guidance for analysts and HTA bodies on selecting robust modeling approaches in rare disease contexts.

  • MSR147 Accounting for Study Heterogeneity When Modelling the Multi-State Natural History of Rare Diseases

    by J. Broomfield, M. Crowther, S. Freeman, K. Abrams, N. Latimer, M.J. Rutherford

  • Open Access

    Regularized parametric survival modeling to improve risk prediction models

    by J. Hoogland, T. P. A. Debray, M. J. Crowther, R. D. Riley, J. IntHout, J. B. Reitsma, A. H. Zwinderman

    We propose to combine the benefits of flexible parametric survival modeling and regularization to improve risk prediction modeling in the context of time‐to‐event data. Thereto, we introduce ridge, lasso, elastic net, and group lasso penalties for both log hazard and log cumulative hazard models. The log (cumulative) hazard in these models is represented by a flexible function of time that may depend on the covariates (i.e., covariate effects may be time‐varying). We show that the optimization problem for the proposed models can be formulated as a convex optimization problem and provide a user‐friendly R implementation for model fitting and penalty parameter selection based on cross‐validation. Simulation study results show the advantage of regularization in terms of increased out‐of‐sample prediction accuracy and improved calibration and discrimination of predicted survival probabilities, especially when sample size was relatively small with respect to model complexity. An applied example illustrates the proposed methods. In summary, our work provides both a foundation for and an easily accessible implementation of regularized parametric survival modeling and suggests that it improves out‐of‐sample prediction performance.

  • Open Access

    P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival

    by Joachim Baech, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly, Daniel Molin, Ingrid Glimelius, Joshua P. Entrop, Michael J. Crowther, Karin E. Smedby, Sandra Eloranta, Caroline E. Weibull

  • Open Access

    A scoping methodological review of simulation studies comparing statistical and machine learning approaches to risk prediction for time-to-event data

    by Hayley Smith, Michael Sweeting, Tim Morris, Michael J. Crowther

    Background: There is substantial interest in the adaptation and application of so-called machine learning approaches to prognostic modelling of censored time-to-event data. These methods must be compared and evaluated against existing methods in a variety of scenarios to determine their predictive performance. A scoping review of how machine learning methods have been compared to traditional survival models is important to identify the comparisons that have been made and issues where they are lacking, biased towards one approach or misleading.Methods: We conducted a scoping review of research articles published between 1 January 2000 and 2 December 2020 using PubMed. Eligible articles were those that used simulation studies to compare statistical and machine learning methods for risk prediction with a time-to-event outcome in a medical/healthcare setting. We focus on data-generating mechanisms (DGMs), the methods that have been compared, the estimands of the simulation studies, and the performance measures used to evaluate them.Results: A total of ten articles were identified as eligible for the review. Six of the articles evaluated a method that was developed by the authors, four of which were machine learning methods, and the results almost always stated that this developed method’s performance was equivalent to or better than the other methods compared. Comparisons were often biased towards the novel approach, with the majority only comparing against a basic Cox proportional hazards model, and in scenarios where it is clear it would not perform well. In many of the articles reviewed, key information was unclear, such as the number of simulation repetitions and how performance measures were calculated.Conclusion: It is vital that method comparisons are unbiased and comprehensive, and this should be the goal even if realising it is difficult. Fully assessing how newly developed methods perform and how they compare to a variety of traditional statistical methods for prognostic modelling is imperative as these methods are already being applied in clinical contexts. Evaluations of the performance and usefulness of recently developed methods for risk prediction should be continued and reporting standards improved as these methods become increasingly popular.


  • Open Access

    A flexible parametric accelerated failure time model and the extension to time-dependent acceleration factors

    by Michael J Crowther, Patrick Royston, Mark Clements

    Summary: Accelerated failure time (AFT) models are used widely in medical research, though to a much lesser extent than proportional hazards models. In an AFT model, the effect of covariates act to accelerate or decelerate the time to event of interest, that is, shorten or extend the time to event. Commonly used parametric AFT models are limited in the underlying shapes that they can capture. In this article, we propose a general parametric AFT model, and in particular concentrate on using restricted cubic splines to model the baseline to provide substantial flexibility. We then extend the model to accommodate time-dependent acceleration factors. Delayed entry is also allowed, and hence, time-dependent covariates. We evaluate the proposed model through simulation, showing substantial improvements compared to standard parametric AFT models. We also show analytically and through simulations that the AFT models are collapsible, suggesting that this model class will be well suited to causal inference. We illustrate the methods with a data set of patients with breast cancer. Finally, we provide highly efficient, user-friendly Stata, and R software packages.


  • Re: Spline‐based accelerated failure time model

    by Mark Clements, Benjamin Christoffersen, Patrick Royston, Michael Crowther

  • INTEREST: INteractive Tool for Exploring REsults from Simulation sTudies

    by Alessandro Gasparini, Tim P. Morris, Michael J. Crowther

    Simulation studies allow us to explore the properties of statistical methods.They provide a powerful tool with a multiplicity of aims; among others: evaluating and comparing new or existing statistical methods, assessing violations of modelling assumptions, helping with the understanding of statistical concepts, and supporting the design of clinical trials.The increased availability of powerful computational tools and usable software has contributed to the rise of simulation studies in the current literature.However, simulation studies involve increasingly complex designs, making it difficult to provide all relevant results clearly.Dissemination of results plays a focal role in simulation studies: it can drive applied analysts to use methods that have been shown to perform well in their settings, guide researchers to develop new methods in a promising direction, and provide insights into less established methods.It is crucial that we can digest relevant results of simulation studies.Therefore, we developed INTEREST: an INteractive Tool for Exploring REsults from Simulation sTudies.The tool has been developed using the Shiny framework in R and is available as a web app or as a standalone package.It requires uploading a tidy format dataset with the results of a simulation study in R, Stata, SAS, SPSS, or comma-separated format.A variety of performance measures are estimated automatically along with Monte Carlo standard errors; results and performance summaries are displayed both in tabular and graphical fashion, with a wide variety of available plots.Consequently, the reader can focus on simulation parameters and estimands of most interest.In conclusion, INTEREST can facilitate the investigation of results from simulation studies and supplement the reporting of results, allowing researchers to share detailed results from their simulations and readers to explore them freely.


  • Open Access

    Individual participant data meta-analysis with mixed-effects transformation models

    by Bálint Tamási, Michael Crowther, Milo Alan Puhan, Ewout W Steyerberg, Torsten Hothorn

    Summary: One-stage meta-analysis of individual participant data (IPD) poses several statistical and computational challenges. For time-to-event outcomes, the approach requires the estimation of complicated nonlinear mixed-effects models that are flexible enough to realistically capture the most important characteristics of the IPD. We present a model class that incorporates general normally distributed random effects into linear transformation models. We discuss extensions to model between-study heterogeneity in baseline risks and covariate effects and also relax the assumption of proportional hazards. Within the proposed framework, data with arbitrary random censoring patterns can be handled. The accompanying $\textsf{R}$ package tramME utilizes the Laplace approximation and automatic differentiation to perform efficient maximum likelihood estimation and inference in mixed-effects transformation models. We compare several variants of our model to predict the survival of patients with chronic obstructive pulmonary disease using a large data set of prognostic studies. Finally, a simulation study is presented that verifies the correctness of the implementation and highlights its efficiency compared to an alternative approach.